**Learning Point for this Article:**

Osteonecrosis of the talus is a rare condition affecting fairly young people; MRI is the diagnostic method of choice, and core decompression with intraosseous stem cell injection provides a feasible treatment option for the early-stage talar osteonecrosis.

Introduction {#sec1-1}
============

Talar osteonecrosis is a fairly uncommon entity caused by the disruption of the blood supply to the talus \[[@ref1]\]. Talus is predisposed to osteonecrosis due to its unique anatomy, distinctive extraosseous arterial circulation, and variable intraosseous blood supply \[[@ref1], [@ref2]\]. Both traumatic and atraumatic causes behind the osteonecrosis of the talus have been identified. Traumatic causes constitute of 75% of the cases and involve talar fracture and dislocation of the talar neck \[[@ref3]\]. Atraumatic causes generally include the use of corticosteroids, alcoholism, or smoking, but on some occasions also systemic lupus erythematosus, renal transplant, sickle cell anemia, and thrombophilias can lead to osteonecrosis \[[@ref1]\]. Idiopathic cases of talar osteonecrosis have been described too. On radiographs, talar osteonecrosis can be seen as increased talar dome opacity (sclerosis) with surrounding radiolucent rim. Subsequent crescent subchondral lucency (crescent sign), deformity, and ultimately articular collapse are late manifestations of the talar osteonecrosis \[[@ref1], [@ref4], [@ref5], [@ref6]\]. Magnetic resonance imaging (MRI) is the superior imaging modality to detect osteonecrosis in early stages with sensitivity and specificity up to 99% \[[@ref7]\]. On MRI, the typical initial findings consist of patchy bone marrow edema (increased signal on T2-weighted/fluid-sensitive sequences and decreased signal on T1-weighted images). Later, as radiographic sclerosis develops in the infarcted bone, corresponding low signal on both T1- and T2-weighted images can be detected. The reparative zone between necrotic tissue and viable granulation tissue represents the "double-line sign," a low-signal rim in which the inner aspect becomes high signal on T2-weighted images \[[@ref4], [@ref8]\]. Many classification systems for osteonecrosis exist, and the Association Research Circulation Osseous (ARCO) system was selected for this case report \[[@ref9]\]. To the orthopedic surgeon, the osteonecrosis of the talus represents a dilemma; while several treatment options exist, the outcomes have remained suboptimal \[[@ref10]\]. Moreover, while a plethora of treatment choices is available - including restricted weight-bearing, bracing, bone grafting, core decompression, talectomy, and arthrodesis - no consensus for the ideal treatment strategy for the talar osteonecrosis exists \[[@ref10]\]. Here, we report a successful treatment of early osteonecrosis of the talus (ARCO Stage I) using core decompression combined with intraosseous stem cell and platelet-rich plasma (PRP) injection. This technique has been introduced by Hernigou and Beaujean mainly to treat osteonecrosis ofthe femoral head \[[@ref11]\]. To the best of our knowledge, no prior literature exists where this modified technique had been used to treat talar osteonecrosis.

Case report {#sec1-2}
===========

A 45-year-old man (treated from 11/2014 to 06/2016) with hypertension and hypothyroidism medications had twisted his right ankle while walking his dog. Primarily, he presented edema around the lateral malleolus, and no fracture was detected on radiographs (figure not shown); thus, conservative treatment with ankle brace was initiated. The pain in the ankle persisted for 3 months, and subsequent follow-up radiographs, and eventually MRI of the ankle was performed. The radiographs were normal ([Fig. 1a](#F1){ref-type="fig"}), but the MRI revealed ARC O Stage I osteonecrosis of the talus with increased signal on T2- weighted fat-saturated images and decreased signal on T1- weighted images; an additional minor crescent sign was also present ([Fig. 2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}). Due to the persisting pain and poor strain tolerance, core decompression with stem cell and PRP injection was performed using GPS^®^ III (Gravitational Platelet Separation System; Zimmer-Biomet, Warsaw, Indiana, USA) and BioCUE BMA (Bone Marrow Aspirate \[BMA\] Concentration System; Zimmer-Biomet, Warsaw, Indiana, USA) systems. First, 30 ml of venous blood (including 3 ml of anticoagulant) was collected from the patient and centrifuged for 15 min. Accordingly, 3 ml of PRP was recovered from the centrifuged sample. In operating room under general anesthesia, autologous aspiration of bone marrow-derived stem cells from the right anterior iliac crest was carried out by an orthopedic surgeon. In total, 60 ml of BMA was collected and subsequently centrifuged for 15 min producing 6 ml of concentrated BMA. Finally, the PRP and BMA were mixed producing a total of 9 ml of the injectate. A stab incision on the anteroinferior edge of the medial malleolus was performed, and on fluoroscopic control, a guidance spike was directed into the talus to the region of the osteonecrosis. A 2.7 mm cannulated drill was used to provide core decompression. Routine histopathological specimens were not produced due to typical findings of osteonecrosis on MRI. Next, the PRP-BMA concoction was injected into the osteonecrotic region under fluoroscopic control using a 3 mm aspiration needle ([Fig. 3](#F3){ref-type="fig"}). The incision wound was closed and full weight-bearing was restricted for 4 weeks with free mobilization of the ankle. On 4- week clinical follow-up, the patient presented no pain in the right ankle. Radiographs were normal except for the low mineral density of the bones in general ([Fig. 1b](#F1){ref-type="fig"}). On the 3-month follow-up, the patient had fully resumed to his daily activities and his ankle was symptomless. The MRI revealed virtually complete resolution of the talar osteonecrotic changes ([Fig. 2c](#F2){ref-type="fig"} and [d](#F2){ref-type="fig"}). On the subsequent 15-month follow-up, the patient presented no symptoms and the MRI scan ([Fig. 2e](#F2){ref-type="fig"} and [f](#F2){ref-type="fig"}) as well as the radiographs ([Fig. 1c](#F1){ref-type="fig"}) were normal.

![Mortise projections of the right ankle. After persisting ankle pain, on 3-month follow- up, the radiographs were interpreted as normal with no signs of osteonecrosis (a). On 4-week post-procedure clinical follow-up, the ankle was painless, but due to restricted weight-bearing, the mineral density ofthe ankle had decreased as seen on radiographs (b). On the last follow-up (15 months after the procedure), the ankle was symptomless and radiographs were interpreted as normal (c).](JOCR-8-23-g001){#F1}

![Magnetic resonance imaging (MRI) studies of the right ankle. On the initial MRI, the fluid-sensitive sagittal T2-weighted fat-saturated (a) image shows significant bone marrow edema (hyperintense signal) in the talus. The T1-weighted sagittal image (b) shows corresponding bone marrow edema as hypointense signal in the talus. On both sequences, a minor crescent sign can be distinguished on the talar dome (arrows in a, b). The 3-month follow-up, MRI shows complete resolution of the osteonecrotic appearance in the talus on fluid-sensitive proton density fat- saturated (c) and T1-weighted sagittal images (d). Some patchy osteoporosis can be distinguished (arrows in c). On the 15-month follow-up MRI, the talus appears normal on proton density fat- saturated (e) and on T1-weighted images (f).](JOCR-8-23-g002){#F2}

![The procedure using fluoroscopic guidance, core decompression ofthe talar dome was performed using a guidance spike (arrowhead) and a 2.7 mm drill (arrow) (a). In addition to standard procedure, autologic mesenchymal stem cells combined with platelet-rich plasma were injected into the osteonecrotic region in the talus (b).](JOCR-8-23-g003){#F3}

Discussion {#sec1-3}
==========

The talus is uncommonly affected by osteonecrosis with an unknown incidence. Core decompression has been suggested as an alternative for the treatment of non-traumatic osteonecrosis of the talus without collapse by decreasing intraosseous pressure and promoting revascularization \[[@ref12]\]. A study by Mont et al. concluded that core decompression is a feasible method of treatment for symptomatic osteonecrosis of the talus before collapse; at 7-year follow-up, 14 of the 17 ankles treated by core decompression had excellent or good result \[[@ref13]\]. Another study also supported core decompression in symptomatic atraumatic talar osteonecrosis before collapse by reporting fair to excellent results in 29 of 32 patients \[[@ref14]\]. A more recent study by Marulanda et al. depicted 44 ankles treated with core decompression, out of which 40 (91%) displayed good to excellent clinical outcomes in 4-year follow- up \[[@ref15]\]. Overall, 28% of patients experience radiologic progression of the osteonecrosis \[[@ref13], [@ref14], [@ref15]\]. Moreover, Issa et al. reported in their study that out of 85 ankles treated by core decompression only 17% demonstrated disease progression \[[@ref16]\]. According to a fairly recent systematic review by Gross et al., the recapitulation of these results is that core decompression is an appropriate procedure in patients with early and late stage osteonecrosis secondary to atraumatic etiologies. However, further research is warranted to evaluate the role of core decompression in the treatment of traumatic talar osteonecrosis \[[@ref10]\]. In addition to normal core decompression, Hernigou and Beaujean have introduced a method combining core decompression with intraosseous stem cell and PRP injection in the treatment of osteonecrosis of the femoral head \[[@ref11]\]. Furthermore, two recent meta-analyses by Papakostidis et al. and Piuzzi et al. showed that on early-stage osteonecrosis of the femoral head the combined approach improves patients' prognosis when compared to plain core decompression \[[@ref17], [@ref18]\]. Here, we have described a case with successful treatment of ARCO Stage I talar osteonecrosis using this combined technique. Initially, the patient presented a minor ankle sprain with persisting pain. The radiographs showed no diagnostic findings, and after definitive MRI diagnosis for early talar osteonecrosis, core decompression with stem cell and PRP injection was performed. Due to the typical MRI appearance of osteonecrosis, histopathological samples were not routinely collected. The differential diagnosis on this case might include insufficiency fracture of the talus and transient bone marrow edema, but since persisting pain and the crescent sign seen on MRI, ARCO Stage I osteonecrosis represents the most plausible diagnosis. On follow-up visits, the patient was symptomless and MRI findings of the osteonecrosis were seen to resolve.

Conclusion {#sec1-4}
==========

We conclude that this modified technique is a viable option in the treatment of early talar osteonecrosis; however, future prospects should include a study comparing this combined technique with plain core decompression.

###### Clinical Message

Talar osteonecrosis is a fairly rare entity; however, MRI usually yields a definitive diagnosis. Since osteonecrosis is a progressive disease, treatment options should be considered with haste. Core decompression combined with intraosseous stem cell injection offers a feasible therapy option for the early talar osteonecrosis.
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